Femring Safety Reports submitted to FDA
>>>Help Community - Review Your Femring Side Effect Episode
More Rx Information: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZTotal Femring reports: 19.
Femring FDA safety alerts: No.
Reported hospitalizations: 6.
Take Femring Side Effects Survey, Discuss Femring with others or
Add Your Side Effect to the Community Database
FDA Reported Femring Side Effects: breast tenderness, ovarian cyst, vaginal haemorrhage, metrorrhagia, hydrometra, vulvovaginal mycotic infection, upper respiratory tract infection, menopausal symptoms, disease recurrence, chest pain, procedural pain.
Femring Usage.
If you have questions about Femring, you can ask a Health Expert or Ask Patient Community about Femring.
Femring Side Effects Report #5199913-5
Consumer or non-health professional from UNITED STATES reported FEMRING problem on Dec 21, 2006. Female patient, weighting 119.9 lb, was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: abdominal distension, alopecia, amnesia, breast tenderness, cardiac pacemaker insertion, crying, disturbance in attention, dysmenorrhoea. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with COUMADIN, LANOXIN, DILTIAZEM, PROMETRIUM, OXYTROL, POTASSIUM, DIURETICS. Patient recovered.
Femring Side Effects Report #5249126-3
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 08, 2007. Female patient, weighting 119.9 lb, was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: abdominal distension, alopecia, amnesia, basal cell carcinoma, breast tenderness, cardiac pacemaker insertion, crying, dermal cyst, disturbance in attention. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with COUMADIN, LANOXIN, DILTIAZEM, PROMETRIUM, OXYTROL, POTASSIUM ACETATE, DIURETICS. Patient recovered.
Femring Side Effects Report #5291472-1
Consumer or non-health professional from UNITED STATES reported FEMRING problem on Mar 21, 2007. Female patient, 58 years of age, weighting 115.1 lb, was diagnosed with pruritus genital, vulvovaginal dryness and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: cystitis interstitial, pruritus genital, vulvovaginal dryness, weight decreased. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with SYNTHROID, ESTRADIOL, PROMETRIUM, PROTONIX, PREMARIN. Patient recovered.
Femring Side Effects Report #5291499-X
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 22, 2007. Female patient, 57 years of age, weighting 130.1 lb, was diagnosed with menopause and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: breast tenderness, hydrometra, metrorrhagia, ovarian cyst, therapeutic response unexpected. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with WELLBUTRIN. Patient recovered.
Femring Side Effects Report #5303017-8
Consumer or non-health professional from UNITED STATES reported FEMRING problem on Mar 29, 2007. Female patient, 56 years of age, weighting 158.1 lb, was diagnosed with vulvovaginal dryness and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: abdominal pain, dyspnoea, hiatus hernia, medical device complication, ovarian cyst, procedural pain, thyroid disorder. FEMRING dosage: 0.05 MG, QD; VAGINAL. During the same period patient was treated with SYNTHROID, DIOVAN HCT, PREVACID, NEXIUM, VITAMIN, FISH OIL, POTASSIUM, CALCIUM. Patient was hospitalized. Patient recovered.
Femring Side Effects Report #5330199-4
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on May 02, 2007. Female patient, 61 years of age, weighting 138.0 lb, was diagnosed with menopause and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: breast swelling, breast tenderness, glaucoma. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with CABERGOLINE. Patient recovered.
Femring Side Effects Report #5341169-4
Physician from UNITED STATES reported FEMRING problem on May 17, 2007. Female patient, 38 years of age, weighting 127.0 lb, was diagnosed with hot flush and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: angioedema, chest pain, tachycardia. FEMRING dosage: unknown. During the same period patient was treated with EFFEXOR, NEXIUM, ZYRTEC. Patient was hospitalized. Patient recovered.
Femring Side Effects Report #5347891-8
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 24, 2006. Female patient, 54 years of age, weighting 130.1 lb, was diagnosed with hot flush, night sweats, vulvovaginal dryness and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: uterine cancer, uterine haemorrhage, uterine leiomyoma, vaginal haemorrhage. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with WELLBUTRIN. Patient recovered.
Femring Side Effects Report #5347894-3
Consumer or non-health professional from UNITED STATES reported FEMRING problem on Aug 03, 2006. Female patient, 61 years of age, was diagnosed with menopausal symptoms and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: breast cancer. FEMRING dosage: unknown. During the same period patient was treated with PREMARIN. Patient recovered.
Femring Side Effects Report #5347896-7
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 19, 2006. Female patient, 43 years of age, weighting 136.9 lb, was diagnosed with urinary tract infection and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: amenorrhoea, headache, panic attack, sleep disorder, vaginal haemorrhage. FEMRING dosage: unknown. Patient recovered.
Femring Side Effects Report #5348678-2
Consumer or non-health professional from UNITED STATES reported FEMRING problem on May 24, 2007. Female patient, 49 years of age, weighting 175.0 lb, was diagnosed with menopausal symptoms and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: disease recurrence, hysterectomy, menopausal symptoms, upper respiratory tract infection. FEMRING dosage: 0.05 MG, QD, VAGINAL RING. During the same period patient was treated with CYMBALTA, PREVACID, PREDNISONE, ALPRAZOLAM, HYDROCODONE, PERCOCET. Patient was hospitalized. Patient recovered.
Femring Side Effects Report #5366191-3
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on June 05, 2007. Female patient, 49 years of age, weighting 175.0 lb, was diagnosed with menopausal symptoms and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: menopausal symptoms, upper respiratory tract infection. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with CYMBALTA, PREVACID, PREDNISONE, ALPRAZOLAM, HYDROCODONE, PERCOCET. Patient was hospitalized. Patient recovered.
Femring Side Effects Report #5101961-8
Consumer or non-health professional from UNITED STATES reported FEMRING problem on Aug 23, 2006. Female patient, 57 years of age, weighting 130.1 lb, was diagnosed with menopausal symptoms and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: breast tenderness, hydrometra, metrorrhagia, ovarian cyst. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with WELLBUTRIN. Patient recovered.
Femring Side Effects Report #5107035-4
FEMRING problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 29, 2006. Female patient was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: addison's disease, lymphocytosis. FEMRING dosage: unknown. During the same period patient was treated with FLUVOXAMINE MALEATE, OMEPRAZOLE, MEBEVERINE. Patient recovered.
Femring Side Effects Report #5130176-2
Consumer or non-health professional from UNITED STATES reported FEMRING problem on Sept 29, 2006. Female patient, 57 years of age, weighting 130.1 lb, was diagnosed with menopausal symptoms and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: breast tenderness, hydrometra, metrorrhagia, ovarian cyst. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with WELLBUTRIN. Patient recovered.
Femring Side Effects Report #5199484-3
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 18, 2006. Female patient, 56 years of age, weighting 145.1 lb, was diagnosed with vulvovaginal dryness and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: uterine polyp, vaginal haemorrhage, vulvovaginal mycotic infection. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with PREMPRO, VITAMINS, FOSAMAX. Patient recovered.
Femring Side Effects Report #5379555-9
Consumer or non-health professional from UNITED STATES reported FEMRING problem on June 20, 2007. Female patient, 56 years of age, weighting 194.9 lb, was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: histoplasmosis, medical device complication, pneumonia, procedural pain, skeletal injury. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with SYNTHROID, ACIPHEX, VALIUM, CLONIDINE, BUPROPION, LIPITOR, BONIVA, MIRALAX. Patient was hospitalized. Patient recovered.
Femring Side Effects Report #5392986-6
FEMRING problem was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2007. Female patient, 72 years of age, weighting 153.9 lb, was diagnosed with vulvovaginal dryness and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: biopsy cervix abnormal, chest pain, dizziness, fatigue, feeling abnormal, heart rate irregular, ovarian cyst, throat irritation, uterine enlargement. FEMRING dosage: 0.05 MG, QD, VAGINAL. During the same period patient was treated with AMIODARONE, ASPIRIN, HYZAAR, IMDUR, LOPRESSOR, LUNESTA, NITROSTAT, ZANTAC. Patient was hospitalized. Patient recovered.
Femring Side Effects Report #5449522-5
Consumer or non-health professional from UNITED STATES reported FEMRING problem on Aug 27, 2007. Female patient, 40 years of age, weighting 119.9 lb, was diagnosed with artificial menopause and was treated with FEMRING. After drug was administered, patient experienced the following problems/side effects: disease recurrence, rheumatoid arthritis, vulvovaginal mycotic infection. FEMRING dosage: 0.1 MG, QD, VAGINAL. During the same period patient was treated with SYNTHROID. Patient recovered.
Ask Our Patient Community about Femring |
||
|
|
||
|
|
||
